Showing results (301-310 of 645) with videos related to

Sort By:
Pageof 65
Thrombosis and Haemostasis|July 10, 1998
Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin systemH R Lijnen, J Silence, G Lemmens, et al.
The Journal of Clinical Investigation|March 1, 1982
Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosisC Korninger, O Matsuo, R Suy, et al.
The Journal of Biological Chemistry|February 28, 1997
Staphylokinase requires NH2-terminal proteolysis for plasminogen activationB Schlott, K H Gührs, M Hartmann, et al.
Blood|September 1, 1992
Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis modelY Imura, J M Stassen, S Bunting, et al.
Thrombosis and Haemostasis|August 20, 1986
Pharmacokinetics and effects on fibrinolytic and coagulation parameters of two doses of recombinant tissue-type plasminogen activator in healthy volunteersM Verstraete, C A Su, P Tanswell, et al.
Circulation|October 15, 1996
Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodelingZ Nong, J M Stassen, L Moons, et al.
Thrombosis and Haemostasis|December 30, 1998
4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosisM T Sartori, B Wiman, S Vettore, et al.
Thrombosis and Haemostasis|August 13, 1990
Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)--studies with active site mutagenized plasminogen and plasmin resistant t-PAH R Lijnen, B Van Hoef, F De Cock, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1983
Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assayD C Rijken, I Juhan-Vague, F de Cock, et al.
Journal of Cardiovascular Pharmacology|April 1, 1988
Pharmacokinetics and thrombolytic properties of a nonglycosylated mutant of human tissue-type plasminogen activator, lacking the finger and growth factor domains, in dogs with copper coil-induced coronary artery thrombosisP Cambier, F van de Werf, G R Larsen, et al.
Pageof 65